Radiotherapy Adapted to Spatial and Temporal Variability in Tumor Hypoxia

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 5, 2007, Pages 1496-1504

  Søvik, Åste ^a,b   Malinen, Eirik ^a,b   Skogmo, Hege K ^c   Bentzen, Søren M ^d   Bruland, Øyvind S ^a,b   Olsen, Dag Rune ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adaptive radiotherapy; Hypoxia; IMRT; TCP

Indexed keywords

MAGNETIC RESONANCE; OPTIMIZATION; OXYGENATION; PATIENT MONITORING; PROBABILITY; TUMORS;

ADAPTIVE RADIOTHERAPY; HYPOXIA; IMRT; TCP;

RADIOTHERAPY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DYNAMICS; FEASIBILITY STUDY; HEAD AND NECK TUMOR; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXYGEN CONSUMPTION; OXYGENATION; PATIENT POSITIONING; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RADIOSENSITIVITY; SARCOMA; TISSUE STRUCTURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ANIMALS; CELL HYPOXIA; DOGS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; MAGNETIC RESONANCE IMAGING; PROBABILITY; RADIATION TOLERANCE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SARCOMA;

EID: 34547533720     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.027     Document Type: Article

References (47)

1. Brahme A., and Agren A.K. Optimal dose distribution for eradication of heterogeneous tumours. Acta Oncol 26 (1987) 377-385
2. Stavreva N.A., Stavrev P.V., and Round W.H. A mathematical approach to optimizing the radiation dose distribution in heterogeneous tumours. Acta Oncol 35 (1996) 727-732
3. Bentzen S.M. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
4. Tanderup K., Olsen D.R., and Grau C. Dose painting: Art or science?. Radiother Oncol 79 (2006) 245-248
5. Malinen E., Søvik Å., Hristov D., et al. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 51 (2006) 4903-4921
6. Yang Y., and Xing L. Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys 32 (2005) 1473-1484
7. Vanderstraeten B., Duthoy W., Gersem W.D., et al. [(18)F]fluoro-deoxy-glucose positron emission tomography ([(18)F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT). for head and neck cancer. Radiother Oncol 79 (2006) 249-258
8. Alber M., Paulsen F., Eschmann S.M., and Machulla H.J. On biologically conformal boost dose optimization. Phys Med Biol 48 (2003) N31-N35
9. Vaupel P., Kelleher D.K., and Hockel M. Oxygen status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28 2 Suppl. 8 (2001) 29-35
10. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14 (2004) 198-206
11. Søvik Å., Malinen E., Bruland Ø.S., et al. Optimization of tumor control probability in hypoxic tumors by radiation dose redistribution: A modelling study. Phys Med Biol 52 (2007) 499-513
12. Gray L.H., Conger A.D., Ebert M., et al. The Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26 (1953) 638-648
13. Brizel D.M., Sibley G.S., Prosnitz L.R., et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38 (1997) 285-289
14. Hockel M., Schlenger K., Mitze M., et al. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 6 (1996) 3-9
15. Sundfor K., Lyng H., Trope C.G., et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 54 (2000) 101-107
16. Movsas B., Chapman J.D., Hanlon A.L., et al. Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings. Urology 60 (2002) 634-639
17. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
18. Chapman J.D., Bradley J.D., Eary J.F., et al. Molecular (functional) imaging for radiotherapy applications: An RTOG symposium. Int J Radiat Oncol Biol Phys 55 (2003) 294-301
19. Lewis J.S., and Welch M.J. PET imaging of hypoxia. Q J Nucl Med 45 (2001) 183-188
20. Taylor N.J., Baddeley H., Goodchild K.A., et al. BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging 14 (2001) 156-163
21. Urtasun R.C., Parliament M.B., McEwan A.J., et al. Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside. Br J Cancer 27 Suppl (1996) S209-S212
22. Gallez B., Baudelet C., and Jordan B.F. Assessment of tumor oxygenation by electron paramagnetic resonance: Principles and applications. Nucl Med Reson Biomed 17 (2004) 240-262
23. Rasey J.S., Koh W.J., Evans M.L., et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 36 (1996) 417-428
24. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
25. Apisarnthanarax S., and Chao K.S. Current imaging paradigms in radiation oncology. Radiat Res 163 (2005) 1-25
26. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
27. Mayr N.A., Yuh W.T., Magnotta V.A., et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: A new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 36 (1996) 623-633
28. Yamashita Y., Baba T., Baba Y., et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: Pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 216 (2000) 803-809
29. Cooper R.A., Carrington B.M., Loncaster J.A., et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 57 (2000) 53-59
30. Loncaster J.A., Carrington B.M., Sykes J.R., et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54 (2002) 759-767
31. Haider M.A., Milosevic M., Fyles A., et al. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 62 (2005) 1100-1107
32. Foo S.S., Abbott D.F., Lawrentschuk N., et al. Functional imaging of intratumoral hypoxia. Mol Imaging Biol 6 (2004) 291-305
33. Nahum A.E., and Sanchez-Nieto B. Tumor control probability modelling: Basic principles and applications in treatment planning. Phys Medica XVII Suppl 2 (2001) 13-23
34. Wouters B.G., and Brown J.M. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat Res 147 (1997) 541-550
35. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res 8 Suppl (1985) S13-S19
36. Kutcher G.J., and Burman C. Calculation of complication probability factors for nonuniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
37. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
38. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
39. Webb S., and Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 38 (1993) 653-666
40. Bentzen S.M., and Baumann M. The linear quadratic model in clinical practice. In: Steel G. (Ed). Basic clinical radiobiology. 3rd ed. (2002), Edward Arnold, London 134-146
41. Whillans D.W., and Hunt J.W. A rapid-mixing comparison of the mechanisms of radiosensitization by oxygen and misonidazole in CHO cells. Radiat Res 90 (1982) 126-141
42. Koch C.J., Stobbe C.C., and Bump E.A. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: Quantitative differences found using the radiation sensitizing agent misonidazole or oxygen. Radiat Res 98 (1984) 141-153
43. Padhani A.R., Krohn K.A., Lewis J.S., and Alber M. Imaging oxygenation of human tumours. Eur Radiol 174 (2007) 861-872
44. Lewis J.S., and Welch M.J. PET imaging of hypoxia. Q J Nucl Med 45 (2001) 183-188
45. Achermann R.E., Ohlerth S.M., Rohrer B.C., et al. Oxygenation of spontaneous canine tumors during fractionated radiation therapy. Strahlenther Onkol 180 (2004) 297-305
46. Lyng H., Tanum G., Evensen J.F., et al. Changes in oxygen tension during radiotherapy of head and neck tumours. Acta Oncol 38 (1999) 1037-1042
47. Brahme A., Nilsson J., and Belkic D. Biologically optimized radiation therapy. Acta Oncol 40 (2001) 725-734